Spots Global Cancer Trial Database for peripheral blood
Every month we try and update this database with for peripheral blood cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Palliative Lattice Stereotactic Body Radiotherapy (SBRT) | NCT04133415 | Cancer Palliative Radi... | Lattice stereot... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma | NCT02296684 | Cancer of Head ... Head and Neck C... Neoplasms, Head... Carcinoma, Squa... Squamous Cell C... Squamous Cell C... | MK-3475 (neoadj... Surgery Intensity modul... Image-guided ra... Cisplatin MK-3475 (adjuva... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy | NCT03655444 | Head and Neck S... | Abemaciclib Nivolumab Tumor biopsy Peripheral bloo... EORTC QLQ-30 | 18 Years - | Washington University School of Medicine | |
| Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer | NCT05400681 | Pancreatic Canc... Pancreatic Aden... | 20 Years - 100 Years | Odense University Hospital | ||
| Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer | NCT05400681 | Pancreatic Canc... Pancreatic Aden... | 20 Years - 100 Years | Odense University Hospital | ||
| Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer | NCT05400681 | Pancreatic Canc... Pancreatic Aden... | 20 Years - 100 Years | Odense University Hospital | ||
| Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy | NCT03309462 | Lung Cancer | Miseq sequencer | 18 Years - 80 Years | Shanghai Chest Hospital | |
| Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies | NCT03624686 | Leukemia | peripheral bloo... | 14 Years - | National Taiwan University Hospital | |
| Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma | NCT03623373 | Mantle Cell Lym... | Bendamustine Rituximab Acalabrutinib Cytarabine Leukapheresis Peripheral bloo... Oral rinse Bone marrow col... | 18 Years - 70 Years | Washington University School of Medicine | |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression | NCT03480360 | Acute Myeloid L... Chronic Lymphoc... Chronic Myeloid... Myelodysplasia Myeloproliferat... Myelofibrosis Lymphoma Lymphoma, Non-H... Plasma Cell Dis... | Cyclophosphamid... Fludarabine Total Body Irra... Tacrolimus cellcept g-csf Peripheral Bloo... | 18 Years - 75 Years | Dartmouth-Hitchcock Medical Center | |
| Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | NCT03650764 | Head and Neck S... | Ramucirumab Pembrolizumab EORTC QLQ-30 FACT H&N Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells | NCT01355913 | Myelodysplastic... Chromosmal Aber... Karyotype Evolu... Rare Abnormalit... Cytogenetic Mon... | 18 Years - | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | ||
| BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) | NCT03496662 | Pancreatic Duct... | BMS-813160 Nivolumab Gemcitabine Nab-paclitaxel Biopsy Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy | NCT03655444 | Head and Neck S... | Abemaciclib Nivolumab Tumor biopsy Peripheral bloo... EORTC QLQ-30 | 18 Years - | Washington University School of Medicine | |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy | NCT03655444 | Head and Neck S... | Abemaciclib Nivolumab Tumor biopsy Peripheral bloo... EORTC QLQ-30 | 18 Years - | Washington University School of Medicine | |
| Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGS | NCT02416726 | Lung Cancer | Nextseq500 sequ... | 18 Years - 80 Years | Shanghai Chest Hospital | |
| Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies | NCT02556931 | Myelodysplastic... Chronic Myelomo... Small Lymphocyt... Chronic Lymphoc... Prolymphocytic ... Chronic Myeloid... Chronic Myelopr... Multiple Myelom... Plasma Cell Neo... Plasma Cell Dys... Myelofibrosis Polycythemia Ve... Essential Throm... Plasma Cell Leu... | Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate m... | - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients | NCT05789498 | Lung Cancer Esophageal Canc... | In vitro stimul... | 18 Years - 80 Years | The First Affiliated Hospital of Soochow University | |
| Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies | NCT03624686 | Leukemia | peripheral bloo... | 14 Years - | National Taiwan University Hospital | |
| Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer | NCT03532217 | Metastatic Horm... | PROSTVAC-V PROSTVAC-F Nivolumab Ipilimumab Neoantigen DNA ... TriGrid Deliver... Tumor biopsy Peripheral bloo... Fecal samples Leukapheresis | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
